
Who We Are
BioMarin is a global biotechnology company that relentlessly pursues bold science to translate genetic discoveries into new medicines that advance the future of human health.
Since our founding in 1997, we have applied our scientific expertise in understanding the underlying causes of genetic conditions to create transformative medicines, using a number of treatment modalities.
Using our unparalleled expertise in genetics and molecular biology, we develop medicines for patients with significant unmet medical need. We enlist the best of the best – people with the right technical expertise and a relentless drive to solve real problems – and create an environment that empowers our teams to pursue bold, innovative science. With this distinctive approach to drug discovery, we’ve produced a diverse pipeline of commercial, clinical and preclinical candidates that have well-understood biology and provide an opportunity to be first-to-market or offer a substantial benefit over existing therapeutic options.
About Corporate Groups
It takes a village, and at BioMarin our corporate groups are the people behind our success. Groups such as IT, Finance, Legal, Global Compliance & Ethics, and our People Team provide foundational support of all areas of operation at BioMarin.
BioMarin has experienced substantial growth organically since its inception, primarily over the last decade. This steady growth in both cost structure and staff was essential to BioMarin’s emergence as a leading, fully integrated global biopharmaceutical company with approximately $3 billion in revenues from over 80 countries, a robust R&D pipeline, operating profits, and world-class technical capabilities through its 3,000 employees worldwide. As the company grows, BioMarin leadership desires to optimize the efficiency of its operations for the future through its next phase of growth.
In 2022 BioMarin launched its Enterprise Resource Planning (ERP) enterprise-wide operational initiative transforming the way we work by implementing an ERP system solution, SAP S4 HANA. In Q1, 2025 our first five legal entities went live in SAP, the remaining entities went live in Q1, 2026. Implementing and sustaining a new ERP impacts the entire company The project team is built around the Global Process Workflows as outlined below:
The Reporting Development Lead will be a key member of the Enterprise Data Excellence group within the ERP Center of Excellence (COE). Reporting to the Head of Data Quality, Reporting, and Analytics, this role will manage a team of external report developers to deliver right-first-time KPIs, reporting and dashboarding solutions using SAP DataSphere, SAP Business Data Cloud, SAP Analytics Cloud, and Power BI. The position will also establish and manage an intake process for collecting reporting requirements from business stakeholders and maintain a self-service reporting catalog of all reports, KPIs, and dashboards. Experience with GxP compliance and validation processes within the life sciences industry is essential. Key Responsibilities
Lead and manage a team of external report developers to ensure timely and accurate delivery of reporting solutions.
Oversee the design, development, delivery, and maintenance of reports and dashboards using SAP DataSphere, SAP Business Data Cloud, SAP Analytics Cloud and Power BI.
Develop and manage an intake process for capturing and prioritizing reporting requirements from business stakeholders.
Create and maintain a centralized self-service reporting catalog including all reports, KPIs, and dashboards.
Ensure all reporting solutions adhere to GxP compliance and validation requirements within the life sciences industry.
Collaborate with functional teams, Data Stewards, Global Process Owners (GPOs), Business Process Managers (BPMs), and IT to align reporting solutions with business needs and ERP data standards.
Attend and engage with existing data governance committees to collect requirements, align policies, and provide status updates.
Technical Qualifications:
Preferred Qualifications:
Core Competencies

Founded in 1997, BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery. The company develops and commercializes targeted therapies that address the root cause of the genetic conditions that it seeks to treat, helping to better the lives of those struggling with rare genetic disease. BioMarin discoveries have led to eight first or best-in-class commercial treatments and a pipeline of multiple product candidates applying the same science-driven, patient-forward approach to broader group of genetic disorders. The more innovative solutions developed, the more lives BioMarin can impact.
Recruitment Fraud Alert Notice
Please be aware of fraud or scams from individuals, organizations and/or internet sites claiming to represent BioMarin in recruitment activities. We have an established recruitment process which is required for all posted positions by BioMarin prior to issuing an offer of employment. This BioMarin process requires formal interviews conducted live with personnel representing BioMarin and never requires payments or fees from job applicants. BioMarin does not conduct interviews via texting tools such as RingCentral.
In the event you receive a suspicious email message about recruiting on behalf of BioMarin, unless it’s from a BioMarin authorized recruiting partner, do not provide any personal information or pay any fees. Qualified and interested candidates should apply to current openings directly through this BioMarin website. BioMarin accepts no responsibility for any costs or charges incurred as a result of fraudulent activity.
If you have lost money or provided your personal identifying information, please contact your bank and report the matter to the FBI via www.ic3.gov. We would also suggest you notify your local police department and monitor your credit.
We appreciate your interest in BioMarin & encourage you to visit http://careers.biomarin.com/career-areas to review job opportunities.